Skip to main content

Lindsey Buckley advises clients on executive compensation and employee benefits matters in connection with public and private mergers, acquisitions, restructurings, and other strategic transactions. She regularly advises clients on incentive equity design and implementation, executive employment agreements, severance arrangements, incentive arrangements, change in control arrangements, nonqualified deferred compensation arrangements, Code Section 409A compliance, and the Code Section 280G cleansing process.

Concentrations

  • Executive compensation
  • ERISA
  • Employee benefits
  • Incentive compensation
  • Transactions

主要执业方向

主要执业经验

  • Represented Vista Equity Partners in its $2.6 billion acquisition of Duck Creek Technologies (NASDAQ: DCT).°
  • Represented Permian Resources Corporation in its $4.5 billion all-stock acquisition of Earthstone Energy, Inc.°
  • Represented KKR in its acquisition of a majority equity stake in Avantus, a premier developer of large utility-scale solar and solar-plus-storage projects.°
  • Represented KKR and its portfolio company, Kito Crosby, a provider of lifting solutions, in its $2.7 billion sale to Columbus McKinnon Corporation.°
  • Represented Littlejohn & Co., LLC on the close of a continuation vehicle anchored by the Valcourt Group.°
  • Represented Bain Capital Insurance in its investment in 1970 Group, a provider of specialized risk financing.°
  • Represented AE Industrial Partners in its $1.3 billion sale of Belcan to Cognizant (NASDAQ: CTSH).°
  • Represented TPG in its sale of CLEAResult to Kohlberg & Company.°
  • Represented Apax Digital Funds in its strategic investment in Petvisor.°
  • Represented Davis-Standard LLC on the acquisition of the Extrusion Technology Group from Dutch Investor Nimbus.°
  • Represented Paya Holdings Inc. in its sale to Nuvei Corporation for approximately $1.3 billion.°
  • Represented Twin Ridge Capital Acquisition Corp. (NYSE: TRCA), a publicly traded special purpose acquisition company, in its $270 million business combination with Carbon Revolution Limited (ASX: CBR).°
  • Represented CarepathRx Holding Company in its agreement to sell BioPlus Specialty Pharmacy, the nation’s largest independent specialty pharmacy, to Elevance Health (NYSE:ELV).°

°The above representations were handled by Ms. Buckley prior to her joining Greenberg Traurig, LLP.

资历

教育
  • J.D., University of Pittsburgh School of Law
  • B.A., cum laude, Chatham College
获准执业地区
  • District of Columbia
  • Pennsylvania

Related Capabilities

Tax